Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)

This study has been completed.
Children's Research Institute
Information provided by (Responsible Party):
Roger Packer, Children's Research Institute
ClinicalTrials.gov Identifier:
First received: May 13, 2009
Last updated: September 12, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)